Publications - 'B'

Publications 176 - 200 de 850
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Beneficial traits of root endophytes and rhizobacteria associated with plants growing in phytomanaged soils with mixed trace metal-polycyclic aromatic hydrocarbon contamination
P.S. Kidd; A. Alvarez; V. Alvarez-Lopez; A. Cerdeira-Perez; B. Rodriguez-Garrido; A. Prieto-Fernandez; M. Chalot
2021
10.1016/j.chemosphere.2021.130272
Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
A. De Nonneville; C. Jauffret; A. Goncalves; J.M. Classe; M. Cohen; F. Reyal; C. Mazouni; M.P. Chauvet; N. Chopin; P.E. Colombo; E. Jouve; E. Darai; R. Rouzier; C. Coutant; P. Gimbergues; A.S. Azuar; T. de Lara; E. Lambaudie; G. Houvenaeghel
2018
Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
A. De Nonneville; C. Jauffret; A. Goncalves; J.M. Classe; M. Cohen; F. Reyal; C. Mazouni; M.P. Chauvet; N. Chopin; P.E. Colombo; E. Jouve; E. Darai; R. Rouzier; C. Coutant; P. Gimbergues; A.S. Azuar; T. de Lara; E. Lambaudie; G. Houvenaeghel
2018
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study
A. de Nonneville; A. Goncalves; C. Zemmour; J.M. Classe; M. Cohen; E. Lambaudie; F. Reyal; C. Scherer; X. Muracciole; P.E. Colombo; S. Giard; R. Rouzier; R. Villet; N. Chopin; E. Darai; J.R. Garbay; P. Gimbergues; L. Sabiani; C. Coutant; R. Sabatier; F. Bertucci; J.M. Boher; G. Houvenaeghel
2017
10.1007/s10549-017-4136-5
Benefit of adjuvant systemic therapies in HR1 HER2-pT1ab node-negative breast carcinomas
A. De Nonneville; A. Goncalves; J.M. Boher; J.M. Classe; M. Cohen; P.E. Colombo; F. Reyal; M.P. Chauvet; E. Jouve; E. Darai; G. Blache; C. Coutant; P. Gimbergues; C. Mazouni; R. Rouzier; R. Villet; P. Crochet; A.S. Azuar; E. Lambaudie; G. Houvenaeghel
2018
Benefit of adjuvant systemic therapies in HR1 HER2-pT1ab node-negative breast carcinomas
A. De Nonneville; A. Goncalves; J.M. Boher; J.M. Classe; M. Cohen; P.E. Colombo; F. Reyal; M.P. Chauvet; E. Jouve; E. Darai; G. Blache; C. Coutant; P. Gimbergues; C. Mazouni; R. Rouzier; R. Villet; P. Crochet; A.S. Azuar; E. Lambaudie; G. Houvenaeghel
2018
BENEFIT OF COMBINING CURCUMIN, HARPAGOPHYTUM AND BROMELAIN TO REDUCE INFLAMMATION IN OSTEOARTHRITIC SYNOVIAL CELLS
S. Brochard; K. Boumediene; T. Conrozier; C. Bauge
2021
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke
P. Amarenco; J.S. Kim; J. Labreuche; H. Charles; M. Giroud; B.C. Lee; M.H. Mahagne; N. Nighoghossian; P.Gabriel Steg; E. Vicaut; E. Bruckert; T.Stroke Tar Investigators
2020
10.1161/STROKEAHA.119.028718
Benefit-risk profile of dabigatran 110 mg versus vitamin-K antagonists in patients with non-valvular atrial fibrillation: A cohort study in the French Nationwide Claims Database
P. Blin; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; J. Benichou; Y. Cottin; P. Mismetti; C. Droz-Perroteau; N. Moore
2018
Benefit-risk profile of dabigatran 150 mg versus vitamin-K antagonists in patients with non-valvular atrial fibrillation: Results from a matched cohort study in the French Nationwide Claims Database
P. Blin; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; J. Benichou; Y. Cottin; P. Mismetti; C. Droz-Perroteau; N. Moore
2018
Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: A cohort study in the French Nationwide Claims Database
P. Blin; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; J. Benichou; Y. Cottin; P. Mismetti; C. Droz-Perroteau; N. Moore
2018
Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database
Y. Cottin; P. Blin; J. Benichou; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; C. Droz-Perroteau; P. Mismetti; N. Moore
2018
Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study
T. Kamel; J. Helms; R. Janssen-Langenstein; A. Kouatchet; A. Guillon; J. Bourenne; D. Contou; C. Guervilly; R. Coudroy; M.Anne Hoppe; J.Baptiste Lascarrou; J.Pierre Quenot; G. Colin; P. Meng; J. Roustan; C. Cracco; M.A. Nay; T. Boulain; C.Res Intens Sepsis
2020
10.1007/s00134-019-05896-4
Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice
T. Maitre; P. Muret; M. Blot; A. Waldner; M. Duong; A. SI-Mohammed; P. Chavanet; S. Aho; L. Piroth
2019
10.2174/1570162X17666190903232053
Benefits of an oocyte pickup simulation training program using a high-fidelity simulator (PickUpSim(TM)) for obstetrics and gynaecology residents: an observational survey study
R. Corroenne; G. Legendre; D. Riethmuller; H. El-Hachem; K.H. Zhu; C. Dreux; P. Jeanneateau; C. Verhaeghe; P. May-Panloup; P. Descamps; P.E. Bouet
2021
10.1080/01443615.2020.1789951
Benefits of Argan Oil on Human Health-May 4-6 2017, Errachidia, Morocco
G. Lizard; Y. Filali-Zegzouti; A.El Midaoui
2017
10.3390/ijms18071383
BENEFITS OF COMPRESSION GARMENTS WORN DURING HANDBALL-SPECIFIC CIRCUIT ON SHORT-TERM FATIGUE IN PROFESSIONAL PLAYERS
G. Ravier; R. Bouzigon; S. Beliard; N. Tordi; F. Grappe
2018
10.1519/JSC.0000000000001342
Benefits of dimension reduction in penalized regression methods for high-dimensional grouped data: a case study in low sample size
S. Ajana; N. Acar; L. Bretillon; B.P. Hejblum; H. Jacqmin-Gadda; C. Delcourt; O. Berdeaux; S. Bouton; A. Bron; B. Buaud; S. Cabaret; A. Cougnard-Gregorie; C. Creuzot-Garcher; M.N. Delyfer; C. Feart-Couret; V. Febvret; S. Gregoire; Z. He; J.F. Korobelnik; L. Martine; B. Merle; C. Vaysse; B.L.I.S.A.R.Study Grp
2019
10.1093/bioinformatics/btz135
Benefits of Direct Colposcopic Vision for Optimal LLETZ Procedure: A Prospective Multicenter Study
L. Preaubert; J. Gondry; J. Mancini; J. Chevreau; G. Lamblin; A. Atallah; V. Lavoue; C. Caradec; J.J. Baldauf; A. Bryand; S. Henno; J. Villeret; A. Agostini; S. Douvier; A. Jarniat; D. Riethmuller; A. Mendel; J.L. Brun; H. Rakotomahenina; X. Carcopino
2016
10.1097/LGT.0000000000000156
Benefits of distal clavicle resection during rotator cuff repair: Prospective randomized single-blind study
D. Gallinet; J. Barth; L. Labattut; P. Collin; P. Metais; N. Bonnevialle; A. Godeneche; J. Garret; P. Clavert; F. Arthros
2020
10.1016/j.otsr.2020.08.006
Benefits of immune protection versus immunopathology costs: A synthesis from cytokine KO models
G. Sorci; C. Lippens; C. Lechenault; B. Faivre
2017
10.1016/j.meegid.2017.08.014
Benefits of metamodel-reduction for nonlinear dynamic response analysis of damaged composite structures
S. Mahmoudi; F. Trivaudey; N. Bouhaddi
2016
10.1016/j.finel.2016.05.001
Benefits of nonlinear analysis indices of walking stride interval in the evaluation of neurodegenerative diseases
F. Dierick; C. Vandevoorde; F. Chantraine; O. White; F. Buisseret
2021
10.1016/j.humov.2020.102741
Benefits of soil carbon: report on the outcomes of an international scientific committee on problems of the environment rapid assessment workshop
S.S. Banwart; H.B. Black; Z.Z. Cai; P.G. Gicheru; H.J. Joosten; R.V. Victoria; E.E. Milne; E.N. Noellemeyer; U.P. Pascual; G.G. Nziguheba; R.R. Vargas; A.B. Bationo; D.B. Buschiazzo; D.D. de-Brogniez; J.M. Melillo; D.R. Richter; M.T. Termansen; M.N. van Noordwijk; T.G. Goverse; C.C. Ballabio; T.B. Bhattacharyya; M.M. Goldhaber; N.N. Nikolaidis; Y.Z. Zhao; R.F. Funk; C.C. Duffy; G.P. Pan; N.L. la Scala; P.G. Gottschalk; N.B. Batjes; J. Six; B.W. van Wesemael; M.S. Stocking; F.B. Bampa; M.B. Bernoux; C.C. Feller; P.P. Lemanceau; L.L. Montanarella
2014
10.1080/17583004.2014.913380
Benefits of the Mediterranean Diet-Wine Association: The Role of Ingredients
P. Silva; N. Latruffe
2022
10.3390/molecules27041273

Pages